Summary:

• Organs within the same individual can age at different rates.
• A simple blood test can determine the biological age of specific organs.
• Accelerated aging in certain organs predicts higher risk for related diseases.
• Rapid immune system aging is linked to increased dementia risk.
• Future healthcare may focus on personalized disease prevention based on organ-specific aging.

Recent research led by University College London (UCL) has unveiled that our organs do not age uniformly; instead, each can age at its own pace. This discovery opens the door to predicting disease risks decades in advance through a straightforward blood test that assesses the biological age of individual organs.

The study, published in The Lancet Digital Health, analyzed data from over 6,200 middle-aged adults participating in the British Whitehall II study. Blood samples collected in the late 1990s were used to determine the biological age of nine organs: heart, blood vessels, liver, immune system, pancreas, kidneys, lungs, intestines, and the brain. The findings revealed that organs often aged at different rates within the same person.

Over a 20-year follow-up period, researchers discovered that accelerated aging in specific organs could predict the risk of 30 different diseases. For instance, a rapidly aging heart indicated a higher likelihood of cardiovascular diseases, while accelerated lung aging was associated with respiratory infections, chronic obstructive pulmonary disease (COPD), and lung cancer.

One surprising outcome was the link between the immune system’s aging and dementia risk. Individuals whose immune systems aged faster were more prone to developing dementia, suggesting that inflammatory processes may play a crucial role in neurodegenerative diseases.

The study also highlighted the interconnectedness of our organs. Accelerated aging in one organ can impair the function of others, leading to multiple age-related diseases across different organs. For example, those with rapidly aging kidneys were more likely to develop vascular disease, type 2 diabetes, and liver diseases.

Advancements in proteomic analyses now allow thousands of proteins to be measured simultaneously from a single blood sample. This technological leap offers a valuable window into monitoring the pace of aging and supports a shift toward more personalized and effective disease prevention. With proteomic signatures of organ aging, risks can be identified earlier, and interventions can be tailored to each person’s unique profile.

Lead author Professor Mika Kivimaki envisions a future where healthcare prioritizes early prevention of age-related diseases, tailoring interventions to individual risk profiles. Such proactive measures could help individuals maintain their health and quality of life as they age.

Source: (sciencedaily.com)